EAM Investors, LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 199 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
EAM Investors, LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2014$2,055,000
+49.9%
112,578
+98.8%
0.29%
+17.1%
Q4 2013$1,371,000
-51.3%
56,636
-28.7%
0.24%
-56.4%
Q3 2013$2,816,000
-18.4%
79,486
-64.1%
0.56%
-25.0%
Q2 2013$3,452,000–221,121–0.75%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders